Microbion Corporation logo — Developing a disruptive new class of therapeutic drugs for t...

Microbion Corporation

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases

Founded 2000 United States Bozeman, United States 16 employees Series Unknown Biotechnology, Health Care +2

General Information

Company Name Microbion Corporation
Founded Year 2000
Location United States Bozeman, United States +2
Employees 16
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series Unknown
Social

Get notified when Microbion Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Microbion Corporation

Microbion Corporation is a clinical-stage pharmaceutical company focusing on developing therapeutic compounds for rare and serious diseases. The company's lead drug candidate, pravibismane, has received substantial support, totaling over $21 million in grants from the Cystic Fibrosis Foundation, NIH, US DoD, and CARB-X. Pravibismane has been granted Orphan Drug, Fast Track, and QIDP designations by the FDA and is currently in clinical development for chronic lung diseases and chronic wounds and orthopedic infections. The drug's potent effectiveness against a broad spectrum of pathogens, including "superbugs" as identified by the US CDC, makes it a promising development in the battle against antibiotic resistance. Additionally, Microbion’s site-specific delivery approach is designed to achieve higher therapeutic concentrations at the site of infection and minimize the risk of antibiotic resistance. The company, founded in 2000 and headquartered in the United States, recently received a Venture - Series Unknown investment at 31 March 2021.

Taxonomy: Pharmaceuticals, Therapeutics, Drug Development, Clinical-stage Biotechnology, Microbial Biofilm Prevention, Chronic Lung Diseases, Orthopedic Infections, Rare Disease Treatments, Antibiotic Resistance, Inhaled Drug Delivery, Topical Drug Development, Medical Device Coatings, Biofilm Prevention Technologies, Agricultural Biofilm Prevention, Industrial Biofilm Prevention

No funding data available for Microbion Corporation yet.

Get notified when Microbion Corporation raises funding

Microbion Corporation Alternatives & Competitors

Microbion Corporation vs

Activaero was a therapeutic area specialist developing cutting-edge solutions for patients suffering...

Grant
3 employees
Biotechnology, Health Care
Microbion Corporation vs

Dedicated to the development of novel therapies to improve the lives of patients with respiratory di...

Series B
13 employees
Health Care, Health and Wellness
Microbion Corporation vs
ContraFect Corp
ContraFect Corp United States

...focused on discovering & developing differentiated biologic therapies for life-threatening, drug-...

Post Ipo Equity
10 employees
Biotechnology, Health Care

FAQ About Microbion Corporation

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases
Microbion Corporation was founded in 2000.
Microbion Corporation is headquartered in Bozeman, United States.
Microbion Corporation operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Microbion Corporation has approximately 16 employees.
Top alternatives and competitors to Microbion Corporation include Activaero GmbH, Enterprise Therapeutics, ContraFect Corp, Syntara, Kinvard Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microbion Corporation and Activaero GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Microbion Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy